Latest Marksans Pharma stock price
Marksans Pharma P/E Ratio
MARKSANS • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
21.34
Moderate Valuation
High - Growth expectations or overvalued
Current Valuation Metrics
P/E Ratio
21.34
Current Price
₹179.27
EPS (TTM)
₹8.40
Exchange
NSE
Valuation Signal
Signal
Overvalued
Historical Avg
11.26
Historical Range
3.55 - 19.76
Percentile
100.0%
Sector Context
Sector Average
22.27
Sector Median
22.27
Sector Rank
#1 of 1
Sector Percentile
100.0%
Earnings Breakdown (TTM)
TTM EPS
₹7.59
Sept 2025
₹2.17
Mar 2025
₹2.00
Key P/E Ratio Insights for Marksans Pharma
- Current PE is 89.5% above historical average
View the MARKSANS equity price for detailed stock performance.
P/E Ratio Historical Trend for Marksans Pharma
Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.
Related Pages for Marksans Pharma
Additional stock information and data for MARKSANS
Historical P/E Ratio Data
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2024 | 19.76 | 8.13 | ₹160.65 | NSE | Moderate |
| 2023 | 8.21 | 7.17 | ₹58.85 | NSE | Low |
| 2022 | 11.82 | 5.23 | ₹61.80 | NSE | Low |
| 2021 | 10.6 | 5.75 | ₹60.95 | NSE | Low |
| 2020 | 3.55 | 4.83 | ₹17.15 | NSE | Low |
| 2019 | 13.62 | 2.07 | ₹28.20 | NSE | Low |
Sector P/E Ratio Comparison
Comparing Marksans Pharma with other companies in Healthcare sector
Sector Average
22.27
Sector Median
22.27
Lowest P/E
22.27
Highest P/E
22.27
Companies
1
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| SMS Lifesciences | SMSLIFE | 22.27 | ₹354 | Moderate |